Alternative Data for LeMaitre Vascular
| Alternative Data | Value | 3m Change | Trend | Benchmark | |
|---|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up | |
| Sentiment | 83 | Sign up | Sign up | Sign up | |
| Webpage traffic | 10,000 | Sign up | Sign up | Sign up | |
| Employee Rating | 66 | Sign up | Sign up | Sign up | |
| Google Trends | N/A | Sign up | Sign up | Sign up | |
| Patents | N/A | Sign up | Sign up | Sign up | |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up | |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up | |
| Stocktwits Subscribers | 514 | Sign up | Sign up | Sign up | |
| X Followers | 413 | Sign up | Sign up | Sign up | |
| X Mentions | 2 | Sign up | Sign up | Sign up | |
| Youtube Subscribers | 411 | Sign up | Sign up | Sign up | |
| News Mentions | N/A | Sign up | Sign up | Sign up | |
| Customer reviews | N/A | Sign up | Sign up | Sign up | |
| ESG | N/A | Sign up | Sign up | Sign up | |
| Business Outlook | 46 | Sign up | Sign up | Sign up |
About LeMaitre Vascular
LeMaitre Vascular Inc provides medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons.
| Price | $85.33 |
| Target Price | Sign up |
| Volume | 100,720 |
| Market Cap | $1.91B |
| Year Range | $78.77 - $100.09 |
| Dividend Yield | 0.89% |
| PE Ratio | 36.3 |
| Analyst Rating | 100% buy |
| Industry | Medical & Dental Instruments |
In the news
North America Leads the Sterilization Equipment Market with 39.13% Revenue in 2025 as Global Market Size Set to Surpass USD 14.72B by 2031 says a 2026 Mordor Intelligence ReportJanuary 26 - GlobeNewswire |
|
![]() |
Reviewing All My Stocks – December Dividend Income ReportJanuary 15 - Thedividendguyblog.com |
![]() |
Reviewing All My Stocks - December Dividend Income ReportJanuary 14 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 61M | 15M | 46M | 17M | 26M | 0.620 |
| Q2 '25 | 64M | 19M | 45M | 14M | 22M | 0.600 |
| Q1 '25 | 60M | 18M | 41M | 11M | 18M | 0.480 |
| Q4 '24 | 56M | 17M | 39M | 11M | 20M | 0.490 |
| Q3 '24 | 55M | 18M | 37M | 11M | 16M | 0.490 |
Insider Transactions View All
| Jasinski Lawrence J filed to sell 4,773 shares at $92.8. August 14 '25 |
| Roberts David B filed to sell 17,976 shares at $92.4. August 13 '25 |
| Roberts David B filed to sell 17,976 shares at $91.5. August 13 '25 |
| Roberts David B filed to sell 18,360 shares at $92.5. August 13 '25 |
| Roush John A filed to sell 2,916 shares at $91.8. August 13 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
![]() |
Align TechnologyALGN |
$167.04 0.4% | 55 |
![]() |
DentsplyXRAY |
$12.77 0.4% | 29 |
![]() |
iRhythm TechnologiesIRTC |
$156.56 3.1% | 45 |
![]() |
NovoCureNVCR |
$13.05 1.6% | 38 |
![]() |
DanaherDHR |
$235.75 0.4% | 45 |
Read more about LeMaitre Vascular (LMAT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews & business outlook.
FAQ - LeMaitre Vascular
The Market Cap of LeMaitre Vascular is $1.91B.
As of today, LeMaitre Vascular's PE (Price to Earnings) ratio is 36.3.
Currently, the price of one share of LeMaitre Vascular stock is $85.33.
The LMAT stock price chart above provides a comprehensive visual representation of LeMaitre Vascular's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling LeMaitre Vascular shares. Our platform offers an up-to-date LMAT stock price chart, along with technical data analysis and alternative data insights.
Yes, LeMaitre Vascular (LMAT) offers dividends to its shareholders, with a dividend yield of 0.89%. This dividend yield represents LeMaitre Vascular's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering LeMaitre Vascular in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of LeMaitre Vascular are Align Technology, Dentsply, iRhythm Technologies, NovoCure, and Danaher.






